S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Becton, Dickinson and Stock Forecast, Price & News

+0.63 (+0.26%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.23 million shs
Average Volume
1.36 million shs
Market Capitalization
$70.39 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for Becton, Dickinson and and its competitors with MarketBeat's FREE daily newsletter.

Becton, Dickinson and logo

About Becton, Dickinson and

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens; and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.


See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Equipment
Year Founded

Sales & Book Value

Annual Sales
$20.25 billion
Cash Flow
$21.57 per share
Book Value
$82.44 per share


Net Income
$2.09 billion
Pretax Margin




Free Float
Market Cap
$70.39 billion

Company Calendar

Dividend Payable
Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.88 out of 5 stars

Medical Sector

27th out of 1,391 stocks

Surgical & Medical Instruments Industry

4th out of 125 stocks

Analyst Opinion: 2.2Community Rank: 4.3Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -

Becton, Dickinson and (NYSE:BDX) Frequently Asked Questions

Is Becton, Dickinson and a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last twelve months. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Becton, Dickinson and stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BDX, but not buy additional shares or sell existing shares.
View analyst ratings for Becton, Dickinson and
or view top-rated stocks.

How has Becton, Dickinson and's stock price been impacted by COVID-19?

Becton, Dickinson and's stock was trading at $231.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BDX shares have increased by 5.7% and is now trading at $245.09.
View which stocks have been most impacted by COVID-19

Are investors shorting Becton, Dickinson and?

Becton, Dickinson and saw a drop in short interest during the month of October. As of October 15th, there was short interest totaling 2,200,000 shares, a drop of 27.6% from the September 30th total of 3,040,000 shares. Based on an average trading volume of 1,340,000 shares, the short-interest ratio is presently 1.6 days. Currently, 0.8% of the company's shares are short sold.
View Becton, Dickinson and's Short Interest

When is Becton, Dickinson and's next earnings date?

Becton, Dickinson and is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Becton, Dickinson and

How were Becton, Dickinson and's earnings last quarter?

Becton, Dickinson and Company (NYSE:BDX) issued its quarterly earnings data on Thursday, November, 4th. The medical instruments supplier reported $2.59 EPS for the quarter, beating the Zacks' consensus estimate of $2.45 by $0.14. The medical instruments supplier had revenue of $5.10 billion for the quarter, compared to the consensus estimate of $4.91 billion. Becton, Dickinson and had a net margin of 10.22% and a trailing twelve-month return on equity of 15.97%. The company's revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.79 earnings per share.
View Becton, Dickinson and's earnings history

How often does Becton, Dickinson and pay dividends? What is the dividend yield for Becton, Dickinson and?

Becton, Dickinson and declared a quarterly dividend on Thursday, November 4th. Investors of record on Friday, December 10th will be given a dividend of $0.87 per share on Friday, December 31st. This represents a $3.48 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Thursday, December 9th. This is a boost from Becton, Dickinson and's previous quarterly dividend of $0.83.
View Becton, Dickinson and's dividend history

Is Becton, Dickinson and a good dividend stock?

Becton, Dickinson and pays an annual dividend of $3.32 per share and currently has a dividend yield of 1.36%. Becton, Dickinson and has been increasing its dividend for 50 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Becton, Dickinson and is 48.47%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Becton, Dickinson and will have a dividend payout ratio of 24.34% next year. This indicates that Becton, Dickinson and will be able to sustain or increase its dividend.
View Becton, Dickinson and's dividend history.

How will Becton, Dickinson and's stock buyback program work?

Becton, Dickinson and announced that its Board of Directors has approved a share repurchase plan on Thursday, November 4th 2021, which permits the company to repurchase 10,000,000 shares, according to EventVestor. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board of directors believes its stock is undervalued.

What guidance has Becton, Dickinson and issued on next quarter's earnings?

Becton, Dickinson and issued an update on its FY 2022 earnings guidance on Thursday, November, 18th. The company provided EPS guidance of $12.300-$12.500 for the period, compared to the Thomson Reuters consensus estimate of $12.400. The company issued revenue guidance of $19.30 billion-$19.50 billion, compared to the consensus revenue estimate of $19.53 billion.

What price target have analysts set for BDX?

9 brokers have issued 1-year price objectives for Becton, Dickinson and's shares. Their forecasts range from $250.00 to $297.00. On average, they expect Becton, Dickinson and's share price to reach $273.63 in the next year. This suggests a possible upside of 11.6% from the stock's current price.
View analysts' price targets for Becton, Dickinson and
or view top-rated stocks among Wall Street analysts.

Who are Becton, Dickinson and's key executives?

Becton, Dickinson and's management team includes the following people:
  • Thomas E. Polen, Chairman, President & Chief Executive Officer
  • Chris DelOrefice, Chief Financial Officer & Executive Vice President
  • William R. Sigmund, Chief Medical Officer & Executive Vice President
  • Elizabeth McCombs, Chief Technology Officer & Executive VP
  • Jerry Flasz, Chief Information Officer & EVP-Global Services

What is Tom Polen's approval rating as Becton, Dickinson and's CEO?

136 employees have rated Becton, Dickinson and CEO Tom Polen on Glassdoor.com. Tom Polen has an approval rating of 91% among Becton, Dickinson and's employees. This puts Tom Polen in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Becton, Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton, Dickinson and investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), Walt Disney (DIS), Abbott Laboratories (ABT), Intel (INTC), Verizon Communications (VZ), Cisco Systems (CSCO) and CVS Health (CVS).

What is Becton, Dickinson and's stock symbol?

Becton, Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

Who are Becton, Dickinson and's major shareholders?

Becton, Dickinson and's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (6.92%), Wellington Management Group LLP (5.05%), Morgan Stanley (3.42%), Parnassus Investments LLC (1.64%), Parnassus Investments LLC (1.63%) and Massachusetts Financial Services Co. MA (1.55%). Company insiders that own Becton, Dickinson and stock include Claire Fraser, James C Lim, Patrick Kaltenbach, Rebecca W Rimel, Rebecca W Rimel, Ribo Alberto Mas, Roland Goette, Simon D Campion, Thomas J Spoerel, Thomas J Spoerel and Vincent A Forlenza.
View institutional ownership trends for Becton, Dickinson and

Which institutional investors are selling Becton, Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including Flossbach Von Storch AG, Longview Partners Guernsey LTD, BlackRock Inc., Vontobel Asset Management Inc., Retirement Systems of Alabama, Balyasny Asset Management LLC, Comgest Global Investors S.A.S., and United Capital Financial Advisers LLC. Company insiders that have sold Becton, Dickinson and company stock in the last year include Claire Fraser, James C Lim, Rebecca W Rimel, and Thomas J Spoerel.
View insider buying and selling activity for Becton, Dickinson and
or view top insider-selling stocks.

Which institutional investors are buying Becton, Dickinson and stock?

BDX stock was purchased by a variety of institutional investors in the last quarter, including Invesco Ltd., Wellington Management Group LLP, Alliancebernstein L.P., Morgan Stanley, Goldman Sachs Group Inc., California Public Employees Retirement System, Parnassus Investments LLC, and Ninety One UK Ltd.
View insider buying and selling activity for Becton, Dickinson and
or or view top insider-buying stocks.

How do I buy shares of Becton, Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Becton, Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $245.09.

How much money does Becton, Dickinson and make?

Becton, Dickinson and has a market capitalization of $70.39 billion and generates $20.25 billion in revenue each year. The medical instruments supplier earns $2.09 billion in net income (profit) each year or $6.85 on an earnings per share basis.

How many employees does Becton, Dickinson and have?

Becton, Dickinson and employs 65,000 workers across the globe.

Does Becton, Dickinson and have any subsidiaries?

The following companies are subsidiares of Becton, Dickinson and: (Bard Istanbul Healthcare Limited Company), Accuri Cytometers, Accuri Cytometers Inc., Adaptec Manufacturing Singapore, Alverix, Alverix Inc., Atto Bioscience, BD Holding S. de R.L. de C.V., BD Infection Prevention BV, BD Kiestra BV, BD Kiestra Total Lab Automation, BD Rapid Diagnostic (Suzhou) Co. Ltd., BD San Luis Potosi S.A. de C.V., BD Switzerland Sarl, BD Ventures LLC, BD West Africa Limited, BDX INO LLC, Bard (Thailand) Limited, Bard ASDI Inc., Bard Access Systems Inc., Bard Acquisition Sub Inc., Bard Australia Pty. Limited, Bard Benelux N.V., Bard Brachytherapy Inc., Bard Brasil Indústria e Comércio de Produtos Para a Saúde Ltda., Bard Canada Inc., Bard Chile S.p.A., Bard Colombia S.A.S., Bard Czech Republic s.r.o., Bard Devices Inc., Bard Dublin ITC Limited, Bard EMEA Finance Center Sp.z o.o., Bard European Distribution Center N.V., Bard Finance B.V. & Co. KG., Bard Financial Services Ltd., Bard Finland OY, Bard France S.A.S., Bard Global Holdings I LLC, Bard Global Holdings II LLC, Bard Global Holdings III LLC, Bard Healthcare Inc., Bard Healthcare Science (Shanghai) Limited, Bard Hellas S.A., Bard Holding SAS, Bard Holdings Limited, Bard Holdings Netherlands B.V., Bard Hong Kong Limited, Bard IP Holdings Inc., Bard India Healthcare Pvt. Ltd., Bard International Holdings B.V., Bard International Inc., Bard Korea Ltd., Bard Limited, Bard MRL Acquisition Corp., Bard Malaysia Healthcare Sdn. Bhd., Bard Medica SA, Bard Medical Devices (Beijing) Co. Ltd., Bard Medical R&D (Shanghai) Co. Ltd., Bard Medical SA (Proprietary) Limited, Bard Mexico Realty S. de R.L. de C.V., Bard Norden AB, Bard Norway AS, Bard Pacific Health Care Company Ltd., Bard Peripheral Vascular Inc., Bard Poland Sp. z.o.o., Bard Productos Plasticos e Medicos Ltda., Bard Reynosa S.A. de C.V., Bard S.r.l., Bard Sdn. Bhd., Bard Shannon Limited, Bard Singapore Private Limited, Bard Sourcing Office Singapore Pte. Ltd., Bard Sweden AB, Bard UK Newco Limited, Bard de Espana S.A., Becton Dickinson (Gibraltar) Holdings Ltd., Becton Dickinson (Gibraltar) Limited, Becton Dickinson (Gibraltar) Management Limited, Becton Dickinson (Mauritius) Limited, Becton Dickinson (Pty) Ltd., Becton Dickinson (Thailand) Limited, Becton Dickinson A.G., Becton Dickinson A/S, Becton Dickinson Argentina S.R.L., Becton Dickinson Asia Holdings Ltd., Becton Dickinson Asia Limited, Becton Dickinson Austria GmbH, Becton Dickinson Austria Holdings GmbH, Becton Dickinson B.V., Becton Dickinson B.V. Saudi Limited Company, Becton Dickinson Benelux N.V., Becton Dickinson Biosciences Systems and Reagents Inc., Becton Dickinson Canada Inc., Becton Dickinson Caribe Ltd., Becton Dickinson Croatia d.o.o., Becton Dickinson Czechia s.r.o., Becton Dickinson Dispensing Belgium BVBA, Becton Dickinson Dispensing Denmark A/S, Becton Dickinson Dispensing France SAS, Becton Dickinson Dispensing Ireland Limited, Becton Dickinson Dispensing Norway, Becton Dickinson Dispensing Spain S.L.U., Becton Dickinson Dispensing UK Ltd., Becton Dickinson Distribution Center N.V., Becton Dickinson East Africa Ltd., Becton Dickinson Euro Finance Sarl, Becton Dickinson Europe Holdings S.A.S., Becton Dickinson France S.A.S., Becton Dickinson GSA Beteilgungs GmbH, Becton Dickinson Global Holdings I Inc., Becton Dickinson Global Holdings II LLC, Becton Dickinson Global Holdings IV LLC, Becton Dickinson Global Holdings V LLC, Becton Dickinson Global Holdings VI LLC, Becton Dickinson Global Holdings VII LLC, Becton Dickinson Global Services Centre Sdn. Bdn., Becton Dickinson GmbH, Becton Dickinson Guatemala S.A., Becton Dickinson Hellas S.A., Becton Dickinson Holdings Limited, Becton Dickinson Holdings Pte Ltd., Becton Dickinson Hungary Kft., Becton Dickinson India Private Limited, Becton Dickinson Industrias Cirurgicas Ltda., Becton Dickinson Infusion Therapy AB, Becton Dickinson Infusion Therapy Holdings UK Limited, Becton Dickinson Infusion Therapy Systems Inc., Becton Dickinson Infusion Therapy Systems Inc. S.A. de C.V., Becton Dickinson Infusion Therapy UK, Becton Dickinson Insulin Syringe Ltd., Becton Dickinson International Holdings II Pte Ltd., Becton Dickinson International Holdings III Pte Ltd., Becton Dickinson International Holdings Pte Ltd., Becton Dickinson Israel Ltd., Becton Dickinson Italia S.p.A., Becton Dickinson Ithalat Ihracat Limited Sirketi, Becton Dickinson Korea Holding Inc., Becton Dickinson Korea Ltd., Becton Dickinson Ltd., Becton Dickinson Luxembourg Finance S.a.r.L., Becton Dickinson Luxembourg Global Holdings Sarl, Becton Dickinson Luxembourg Holdings II S.a.r.L, Becton Dickinson Luxembourg Holdings III S.a.r.L, Becton Dickinson Malaysia Inc., Becton Dickinson Management GmbH & Co. KG, Becton Dickinson Matrex Holdings Inc., Becton Dickinson Medical (S) Pte Ltd., Becton Dickinson Medical Devices (Shanghai) Co. Ltd., Becton Dickinson Medical Devices (Suzhou) Co. Ltd., Becton Dickinson Medical Products Pte. Ltd., Becton Dickinson Medical Technology (Jiangsu) Co. Ltd., Becton Dickinson Netherlands Global Holdings II C.V., Becton Dickinson Netherlands Holdings B.V., Becton Dickinson Netherlands Holdings II B.V., Becton Dickinson Norway AS, Becton Dickinson O.Y., Becton Dickinson Overseas Services Ltd., Becton Dickinson Pakistan (Pvt) Ltd., Becton Dickinson Penel Limited, Becton Dickinson Philippines Inc., Becton Dickinson Polska Sp.z.o.o., Becton Dickinson Portugal Unipessoal Lda., Becton Dickinson Pty. Ltd., Becton Dickinson Research Centre Ireland Limited, Becton Dickinson Rowa Germany GmbH, Becton Dickinson Rowa Italy Srl, Becton Dickinson S.A., Becton Dickinson Sample Collection GmbH, Becton Dickinson Scot Financing L.L.P., Becton Dickinson Scot Financing L.P., Becton Dickinson Sdn. Bhd., Becton Dickinson Slovakia s.r.o., Becton Dickinson Sweden AB, Becton Dickinson Sweden Holdings AB, Becton Dickinson Switzerland Global Holdings SarL, Becton Dickinson Technology Campus India, Becton Dickinson U.K. Limited, Becton Dickinson UK Financing I Ltd., Becton Dickinson UK Financing II Ltd., Becton Dickinson Venezuela C.A., Becton Dickinson Venture LLC, Becton Dickinson Verwaltungs GmbH, Becton Dickinson Vostok LLC, Becton Dickinson Worldwide Investments Sa.r.L., Becton Dickinson Zambia Limited, Becton Dickinson and Company Ltd., Becton Dickinson de Colombia Ltda., Becton Dickinson de Mexico S.A. de C.V., Becton Dickinson del Uruguay S.A., Benex Ltd., Biometric Imaging, Bridger Biomed Inc., C. R. Bard, C. R. Bard (Portugal)-Produtos e Artigos Medicos e Farmaceuticos, C. R. Bard Do Brazil Productos Medicos Ltds., C. R. Bard GmbH, C. R. Bard Inc., C. R. Bard Netherlands Sales B.V., CME America LLC, CME Ltd., CME Medical (UK) Limited, CME UK (Holdings) Limited, CRISI Medical Systems, CRISI Medical Systems Inc., Caesarea Medical Electronics, Cardal II LLC, Care Fusion Development Private Limited, CareFusion, CareFusion (Barbados) SrL, CareFusion (Shanghai) Commercial and Trading Co. Limited, CareFusion 213 LLC, CareFusion 2200 Inc., CareFusion 2201 Inc., CareFusion 302 LLC, CareFusion 303 Inc., CareFusion Asia (HK) Limited, CareFusion BH 335 d.o.o. Cazin, CareFusion Corporation, CareFusion D.R. 203 Ltd., CareFusion France 309 S.A.S., CareFusion Germany 318 GmbH, CareFusion Iberia 308 S.L., CareFusion Israel 330 Ltd., CareFusion Italy 312 S.p.A., CareFusion Manufacturing LLC, CareFusion Mexico 215 S.A. de C.V., CareFusion Netherlands 328 B.V., CareFusion Netherlands 503 B.V., CareFusion Netherlands 504 B.V., CareFusion Netherlands Financing 283 C.V., CareFusion Resources LLC, CareFusion S.A. 319 (Proprietary) Limited, CareFusion Solutions LLC, CareFusion U.K. 244 Limited, CareFusion U.K. 305 Limited, CareFusion U.K. 306 Limited, Carmel Pharma AB, Carmel Pharma Inc, Cato Software Solutions, Cell Analysis Systems Inc, Cellular Research, Cellular Research Inc., Clearstream Technologies Group Limited, Clearstream Technologies Limited, Clontech Laboratories Inc, Corporativo BD de Mexico S. de R.L. de C.V., Cubex, Cytopeia, DLD (Bermuda) Ltd., DVL Acquisition Sub Inc., Davol Inc., Davol International Limited, Davol Surgical Innovations S.A. de C.V., Difco Laboratories Incorporated, Distribuidora BD Mexico S.A. de C.V., Dutch American Manufacturers (D.A.M.) B.V., Dymax Corporation, Embo Medical Limited, Enturia de Mexico S. de R.L. de C.V., Enturican Inc., FJ International Inc., FlowCardia Inc., FlowCardia LLC, FlowJo LLC, Franklin Lakes Enterprises L.L.C., GSL Solutions, Gamer Lasertechnik GmbH, GenCell Biosystems, GenCell Biosystems Ltd., GeneOhm Sciences, GeneOhm Sciences Canada Inc., Gentest Corporation, Gesco International Inc., Gesco International LLC, HandyLab Inc, HandyLab Inc., IBD Holdings LLC, Ionotophoretics Corporation, JoHome LLC, Kabushiki Kaisha Medicon (Medicon Inc.), Liberator Health and Education Services Inc., Liberator Health and Wellness Inc., Liberator Medical Holdings Inc., Liberator Medical Supply Inc., LifeBond, Limited Liability Company Bard Rus, Loma Vista Medical Inc., Loma Vista Medical LLC, Lutonix Inc., Med-Design Corporation, Med-Design Investment Holdings Inc., Med-Safe Systems Inc., MedChem Products Inc., Medafor Inc., Medegen LLC, Medinservice.com Inc., Medivance Inc., NAT Diagnostics, NAT Diagnostics Inc., NOW Medical Distribution Inc., NOW Medical Distribution LLC, Navarre Biomedical LLC, Navarre Biomedical Ltd., Neomend Inc., Nippon Becton Dickinson Company Ltd., Omega Biosystems Incorporated, P.R.C.(Isialys)Societe a responsabilitie limitee(Societe a associe unique), PT Becton Dickinson Indonesia, PharMingen, PreAnalytiX GmbH, Pristine Access Technologies Inc., ProSeed Inc., Procesos para Esterilizacion S.A. de C.V., Productos Bard de Mexico S.A. de C.V., Productos Para el Cuidado de la Salud S.A. de C.V., Puls Medical Devices AS LC, PureWick Corporation, Roberts Laboratories Inc., Rochester Medical Corporation, Rochester Medical Ltd., Saf-T-Med, Safety Syringes, Safety Syringes Inc., Sendal S.L.U., SenoRx Inc., SenoRx LLC, Shield Healthcare Centers Inc., Sirigen, Sirigen II Limited, Sirigen Inc., Sistemas Médicos ALARIS S.A. de C.V., Specialized Cooperative Corporation, Specialized Health Products Inc., Specialized Health Products International Inc., Specialized Health Products International LLC, Staged Diabetes Management LLC, Straub Medical, Straub Medical, Straub Medical (US) LLC, Straub Medical (United Kingdom) Ltd., Straub Medical France, Surgical Site Solutions Inc., TVA Medical, TVA Medical GmbH, TVA Medical Inc., Tepha, Touchstone Medical Limited, Tri-County Medical & Ostomy Supplies Inc., TriPath Imaging, TriPath Imaging Inc., Vas-Cath Incorporated, Vascular Pathways Inc., Velano Vascular, Venetec International Inc., Venetec International LLC, Y-Med Inc., and Y-Med LLC.

When was Becton, Dickinson and founded?

Becton, Dickinson and was founded in 1897.

What is Becton, Dickinson and's official website?

The official website for Becton, Dickinson and is www.bd.com.

Where are Becton, Dickinson and's headquarters?

Becton, Dickinson and is headquartered at 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417.

How can I contact Becton, Dickinson and?

Becton, Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at (201) 847-6800 or via fax at 201-847-6475.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.